Clinical Trial Results

Showing: All studies [change]
Condition: Breast Cancer 25 trials found
New Search
Filter
Trial Phase
Study Type
AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer.
NAINTERVENTIONAL Brussels +4 more
RECRUITING
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
PHASE3INTERVENTIONAL Tucson, Arizona +4 more
RECRUITING
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
PHASE1, PHASE2INTERVENTIONAL Fullerton, California +4 more
RECRUITING
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Online Nutrition Education to Decrease the Side Effects of Chemotherapy in Patients With Breast Cancer
NAINTERVENTIONAL Seattle, Washington +4 more
RECRUITING
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
PHASE1INTERVENTIONAL Duarte, California +4 more
RECRUITING
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
PHASE3INTERVENTIONAL Tucson, Arizona +4 more
RECRUITING
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
PHASE1INTERVENTIONAL Denver, Colorado +4 more
RECRUITING
Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast
PHASE2INTERVENTIONAL Cleveland, Ohio +4 more
RECRUITING
DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
PHASE2INTERVENTIONAL Miami, Florida +4 more
RECRUITING
A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors
PHASE1, PHASE2INTERVENTIONAL Saint Louis, Missouri +4 more
RECRUITING
A Study to Investigate Mechanisms of Resistance to Breast Cancer Therapies
PHASE4INTERVENTIONAL Anderlecht +4 more
RECRUITING
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
PHASE1, PHASE2INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer
PHASE2INTERVENTIONAL Boston, Massachusetts +4 more
RECRUITING
Breast Cancer PSMA PET
EARLY_PHASE1INTERVENTIONAL Iowa City, Iowa +4 more
RECRUITING
Social and Environmental Determinants of Breast Cancer Survivorship: the Black Breast Cancer Survivor's Intervention (BBCSI)
NAINTERVENTIONAL Houston, Texas +4 more
RECRUITING
An Optimized Ultrasound Twinkling Marker for the Imaging of Lymph Nodes in Patients With Clinically Node-Positive Breast Cancer, The UTMOST2 Trial
PHASE1INTERVENTIONAL Rochester, Minnesota +4 more
RECRUITING
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
PHASE3INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors
PHASE1INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
PHASE2INTERVENTIONAL Springdale, Arkansas +4 more
RECRUITING
To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer
PHASE2INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
PHASE3INTERVENTIONAL Bloomington, Illinois +4 more
RECRUITING
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
PHASE3INTERVENTIONAL Wollongong, New South Wales +4 more
RECRUITING
Generative AI Patient Education Module for Breast Oncology
NAINTERVENTIONAL San Francisco, California
RECRUITING
Filter Trials
Trial Phase
Study Type